193 related articles for article (PubMed ID: 29807052)
21. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.
Shah K; Perez-Ordóñez B
Head Neck Pathol; 2016 Mar; 10(1):85-94. PubMed ID: 26830400
[TBL] [Abstract][Full Text] [Related]
23. Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies.
Chinezu L; Vasiljevic A; Jouanneau E; François P; Borda A; Trouillas J; Raverot G
Hum Pathol; 2014 Jan; 45(1):71-7. PubMed ID: 24182563
[TBL] [Abstract][Full Text] [Related]
24. [Co-expression of TrkA and p75 neurotrophin receptor in extracranial olfactory neuroblastoma cells].
Zhao SP
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):50-2. PubMed ID: 12934398
[TBL] [Abstract][Full Text] [Related]
25. Review of the cytological features of olfactory neuroblastoma: A retrospective single-center study.
Okano K; Ishida M; Sandoh K; Ito H; Fujisawa T; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E301-E306. PubMed ID: 33629822
[TBL] [Abstract][Full Text] [Related]
26. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.
Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A
Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398
[TBL] [Abstract][Full Text] [Related]
27. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
[TBL] [Abstract][Full Text] [Related]
28. Fine needle aspiration cytology of metastatic olfactory neuroblastoma.
Collins BT; Cramer HM; Hearn SA
Acta Cytol; 1997; 41(3):802-10. PubMed ID: 9167705
[TBL] [Abstract][Full Text] [Related]
29. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
Taraszewska A; Czorniuk-Sliwa A; Dambska M
Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
[TBL] [Abstract][Full Text] [Related]
31. Non-contiguous meningeal metastases of olfactory neuroblastoma.
Jiang W; Liu J; Gullane PJ; Gentili F; Wharen RE; Kim BYS; DeMonte F
J Neurooncol; 2016 Jan; 126(1):201-203. PubMed ID: 26376653
[TBL] [Abstract][Full Text] [Related]
32. Expressions of NeuroD and GAP43 as diagnostic markers for olfactory neuroblastoma.
Furukawa T; Tatehara S; Teshima M; Shinomiya H; Inokuchi G; Komatsu M; Hara S; Zen Y; Nibu KI
Auris Nasus Larynx; 2023 Jun; 50(3):358-364. PubMed ID: 35999123
[TBL] [Abstract][Full Text] [Related]
33. Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.
Kaemmerer D; Peter L; Lupp A; Schulz S; Sänger J; Baum RP; Prasad V; Hommann M
Int J Clin Exp Pathol; 2012; 5(3):187-94. PubMed ID: 22558472
[TBL] [Abstract][Full Text] [Related]
34. Clincopathological analysis of olfactory neuroblastoma.
Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
[TBL] [Abstract][Full Text] [Related]
35. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract][Full Text] [Related]
36. Olfactory neuroblastoma.
Thompson LD
Head Neck Pathol; 2009 Sep; 3(3):252-9. PubMed ID: 20596981
[TBL] [Abstract][Full Text] [Related]
37. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma.
Tao L; Chen Y; Shi X; Yu G; Yin W; Huang Y
Virchows Arch; 2020 Oct; 477(4):573-579. PubMed ID: 32328798
[TBL] [Abstract][Full Text] [Related]
38. OTX1 and OTX2 as possible molecular markers of sinonasal carcinomas and olfactory neuroblastomas.
Pirrone C; Chiaravalli AM; Marando A; Conti A; Rainero A; Pistochini A; Lo Curto F; Pasquali F; Castelnuovo P; Capella C; Porta G
Eur J Histochem; 2017 Feb; 61(1):2730. PubMed ID: 28348423
[TBL] [Abstract][Full Text] [Related]
39. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K
Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704
[TBL] [Abstract][Full Text] [Related]
40. Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.
Herac M; Niederle B; Raderer M; Krebs M; Kaserer K; Koperek O
APMIS; 2016 Oct; 124(10):839-45. PubMed ID: 27539746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
